Home

המלווה הרס דינקרוויל ventilator associated pneumonia treatment לחלוק כבוד יומן משמעות חדשה

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including  ventilator-associated pneumonia (REPROVE): a randomised, double-blind,  phase 3 non-inferiority trial - The Lancet Infectious Diseases
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial - The Lancet Infectious Diseases

Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated  Pneumonia - CHEST
Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated Pneumonia - CHEST

Diagnosis of ventilator-associated pneumonia: a systematic review of the  literature | Critical Care | Full Text
Diagnosis of ventilator-associated pneumonia: a systematic review of the literature | Critical Care | Full Text

JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2  Diagnostic Accuracy: Changing the Paradigm?
JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm?

JCM | Free Full-Text | Epidemiology, Treatment, and Prevention of  Nosocomial Bacterial Pneumonia | HTML
JCM | Free Full-Text | Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia | HTML

The Vexing Problem of Ventilator-Associated Pneumonia: Observations on  Pathophysiology, Public Policy, and Clinical Science | Respiratory Care
The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science | Respiratory Care

Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical  Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE

Levofloxacin in the treatment of ventilator-associated pneumonia - Clinical  Microbiology and Infection
Levofloxacin in the treatment of ventilator-associated pneumonia - Clinical Microbiology and Infection

Summary of the international clinical guidelines for the management of  hospital-acquired and ventilator-acquired pneumonia | European Respiratory  Society
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia | European Respiratory Society

Ventilator-associated pneumonia in patients with SARS-CoV-2-associated  acute respiratory distress syndrome requiring ECMO: a retrospective cohort  study | Annals of Intensive Care | Full Text
Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text

Frontiers | Drug Prevention and Control of Ventilator-Associated Pneumonia
Frontiers | Drug Prevention and Control of Ventilator-Associated Pneumonia

How I diagnose and manage ventilator-associated tracheobronchitis |  Medicina Intensiva
How I diagnose and manage ventilator-associated tracheobronchitis | Medicina Intensiva

The Prevention of Ventilator-Associated Pneumonia | NEJM
The Prevention of Ventilator-Associated Pneumonia | NEJM

Ventilator-associated pneumonia: The central role of transcolonization -  ScienceDirect
Ventilator-associated pneumonia: The central role of transcolonization - ScienceDirect

Management of Ventilator-Associated Pneumonia - Clinics in Chest Medicine
Management of Ventilator-Associated Pneumonia - Clinics in Chest Medicine

Diagnosis and Treatment of Ventilator-Associated Pneumonia - CHEST
Diagnosis and Treatment of Ventilator-Associated Pneumonia - CHEST

Biomarker-guided antibiotic stewardship in suspected ventilator-associated  pneumonia (VAPrapid2): a randomised controlled trial and process evaluation  - The Lancet Respiratory Medicine
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine

Missouri Society of Health-System Pharmacists - Diagnosis and Treatment of  Adults with Community-acquired Pneumonia: 2019 Clinical Practice Guidelines
Missouri Society of Health-System Pharmacists - Diagnosis and Treatment of Adults with Community-acquired Pneumonia: 2019 Clinical Practice Guidelines

Update on ventilator-associated pneumonia | F1000Research
Update on ventilator-associated pneumonia | F1000Research

Ventilator-associated pneumonia: A review of the clinically relevant  challenges in diagnosis and prevention | British Journal of Medical  Practitioners
Ventilator-associated pneumonia: A review of the clinically relevant challenges in diagnosis and prevention | British Journal of Medical Practitioners

Ventilator-associated pneumonia in adults: a narrative review | SpringerLink
Ventilator-associated pneumonia in adults: a narrative review | SpringerLink

Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common  and what is the impact? | Critical Care | Full Text
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact? | Critical Care | Full Text

Ventilator-associated pneumonia in adults: a narrative review | SpringerLink
Ventilator-associated pneumonia in adults: a narrative review | SpringerLink

Empiric treatment VAP (adults) - UpToDate
Empiric treatment VAP (adults) - UpToDate